Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients.
Ezequiel
E
Ridruejo
Raúl
R
Adrover
Daniel
D
Cocozzella
María Virgina
MV
Reggiardo
Nora
N
Fernández
D006526:Hepatitis C / Q000188:drug therapy* / Q000208:ethnology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008913:Minority Groups; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*; D016896:Treatment Outcome; D014505:Urban Population
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a